To develop and clinically validate an innovative cell-free deoxyribonucleic acid (cfdna) based panel for detecting disease-causing fungi directly from plasma.
Active Definitive Contract Awarded Last action
- Contract number
- 75N93026C00010
- Awardee
-
Zepto Life Technology, Inc. UEI ELTELWNJZJ73
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,878,981
Award facts
- Opportunity
-
- 2026 NIAID DMID Omnibus Broad Agency Announcement Pre-Solicitation · HHSNIHNIAIDBAA20251 · Posted Nov 4, 2024
- Contract value 21% obligated
-
- $1,878,981.00 Current, with exercised options
- $8,946,929.00 Potential, with all options
- Completion date 28% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- St Paul, MN 55114, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases awarded a definitive contract to Zepto Life Technology, Inc. for $8.946 million on August 3, 2026, to develop and clinically validate an innovative cell-free deoxyribonucleic acid (cfDNA) based panel for detecting disease-causing fungi directly from plasma.
The contract is priced on a cost, no-fee basis with an ultimate completion date of April 30, 2027. Place of performance is St Paul, Minnesota. The originating solicitation was a Broad Agency Announcement posted November 4, 2024, with a February 21, 2025 proposal due date, seeking research and development of diagnostics for biodefense and emerging infectious diseases. The NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences), and the PSC is AN12 (Health R&D Services).
Quick answers
Who was awarded contract 75N93026C00010?
75N93026C00010 was awarded to Zepto Life Technology, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 3, 2026.
How much is contract 75N93026C00010 worth?
The government has obligated $1,878,981 on 75N93026C00010. Its potential value, with all options, is $8,946,929.
Was contract 75N93026C00010 competed?
The extent of competition for 75N93026C00010 was full and open competition. The government received 7 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award